一体化全外显子组测序策略同步分析拷贝数变异、单核苷酸变异和杂合性缺失在胎儿超声结构异常中的应用:一年经验
该研究对415例超声结构异常且QF-PCR结果非致病的胎儿样本,采用全外显子组亲子三联测序联合全外显子组拷贝数变异分析,并按需同步或快速追加单核苷酸变异分析。所有初始分析在采样后2周内完成,孕期SNV再分析周转时间为1至8天。作者认为该一体化策略高效且周转时间短。
要点
- 对QF-PCR非致病的超声异常胎儿,可先进行全外显子组拷贝数变异分析。
- 若拷贝数变异分析未发现致病变异,可快速追加单核苷酸变异再分析。
- 所有初始分析在采样后2周内完成,SNV再分析周转时间1至8天。
核心结论
- 作者展示了一种高效的一体化全外显子组测序策略,周转时间短,并可在拷贝数变异结果正常后快速进行单核苷酸变异再分析。
研究设计与样本
- 对超声异常且QF-PCR结果非致病的妊娠,在侵入性诊断后行全外显子组亲子三联测序联合全外显子组拷贝数变异分析(WES-CNV)。
- 按需同步进行仅限请求基因面板的单核苷酸变异分析(WES-CNV/SNV),或在校外显子组拷贝数变异分析正常后行快速单核苷酸变异再分析。
- 共纳入415例产前样本。
主要发现
- QF-PCR结果非致病后,初始请求WES-CNV分析者占绒毛膜绒毛样本的74.3%、羊水样本的45%。
- WES-CNV未发现致病变异时,请求SNV再分析者占绒毛膜绒毛样本的41.7%、羊水样本的17.5%。
- 所有初始分析均在采样后2周内完成。
- 孕期SNV再分析的周转时间为1至8天。
临床怎么用
- 作者报告的一体化WES策略可在QF-PCR非致病且胎儿超声异常时,同时分析拷贝数变异、单核苷酸变异和杂合性缺失。
- 作者报告该策略周转时间短,并可在拷贝数变异结果正常后快速进行SNV再分析。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: We performed a 1-year evaluation of a novel strategy of simultaneously analyzing single nucleotide variants (SNVs), copy number variants (CNVs) and copy-number-neutral Absence-of-Heterozygosity from Whole Exome Sequencing (WES) data for prenatal diagnosis of fetuses with ultrasound (US) anomalies and a non-causative QF-PCR result. METHODS: After invasive diagnostics, whole exome parent-offspring trio-sequencing with exome-wide CNV analysis was performed in pregnancies with fetal US anomalies and a non-causative QF-PCR result (WES-CNV). On request, additional SNV-analysis, restricted to (the) requested gene panel(s) only (with the option of whole exome SNV-analysis afterward) was performed simultaneously (WES-CNV/SNV) or as rapid SNV-re-analysis, following a normal CNV analysis. RESULTS: In total, 415 prenatal samples were included. Following a non-causative QF-PCR result, WES-CNV analysis was initially requested for 74.3% of the chorionic villus (CV) samples and 45% of the amniotic fluid (AF) samples. In case WES-CNV analysis did not reveal a causative aberration, SNV-re-analysis was requested in 41.7% of the CV samples and 17.5% of the AF samples. All initial analyses could be finished within 2 weeks after sampling. For SNV-re-analysis during pregnancy, turn-around-times (TATs) varied between one and 8 days. CONCLUSION: We show a highly efficient all-in-one WES-based strategy, with short TATs, and the option of rapid SNV-re-analysis after a normal CNV result.
引用
- Faas BHW, Westra D, de Munnik SA, et al. All-in-one whole exome sequencing strategy with simultaneous copy number variant, single nucleotide variant and absence-of-heterozygosity analysis in fetuses with structural ultrasound anomalies: A 1-year experience. Prenat Diagn. 2023. PMID: 36647814. doi:10.1002/pd.6314
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。